GPT Healthcare Limited (NSE:GPTHEALTH)
India
· Delayed Price · Currency is INR 125.74
+3.42 (2.80%)
At close: Mar 6, 2026
GPT Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 4,476 | 4,071 | 4,002 | 3,610 | 3,374 | 2,428 | Upgrade
|
| Revenue Growth (YoY) | 10.48% | 1.72% | 10.85% | 7.00% | 39.00% | 14.59% | Upgrade
|
| Cost of Revenue | 1,792 | 1,644 | 1,648 | 1,511 | 1,534 | 1,075 | Upgrade
|
| Gross Profit | 2,684 | 2,427 | 2,354 | 2,100 | 1,840 | 1,352 | Upgrade
|
| Selling, General & Admin | 93.68 | 93.68 | 59.97 | 65.87 | 42.12 | 23.47 | Upgrade
|
| Other Operating Expenses | 1,775 | 1,499 | 1,411 | 1,290 | 1,058 | 826.25 | Upgrade
|
| Operating Expenses | 2,119 | 1,783 | 1,651 | 1,505 | 1,236 | 977.75 | Upgrade
|
| Operating Income | 564.9 | 643.23 | 703.45 | 594.4 | 604.51 | 374.55 | Upgrade
|
| Interest Expense | -61.34 | -25.3 | -64.95 | -84.43 | -101.94 | -127.63 | Upgrade
|
| Interest & Investment Income | 48.75 | 48.75 | 36.04 | 38.8 | 39.73 | 39.39 | Upgrade
|
| Other Non Operating Income (Expenses) | -21.29 | 4.69 | -1.22 | -2.98 | -5.91 | -5.45 | Upgrade
|
| EBT Excluding Unusual Items | 531.02 | 671.38 | 673.32 | 545.79 | 536.39 | 280.86 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.01 | 4.01 | 2.9 | 1.79 | 1.93 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.84 | 1.84 | -2.03 | 4.51 | -1.14 | 6.48 | Upgrade
|
| Asset Writedown | 1.5 | 1.5 | 1.01 | - | 1.13 | -9.36 | Upgrade
|
| Other Unusual Items | 14.73 | 14.73 | 5.24 | 7.61 | 2.48 | 10.85 | Upgrade
|
| Pretax Income | 553.1 | 693.46 | 680.43 | 559.69 | 540.79 | 288.83 | Upgrade
|
| Income Tax Expense | 147.65 | 194.24 | 202.74 | 169.62 | 124.16 | 77.9 | Upgrade
|
| Net Income | 405.45 | 499.22 | 477.69 | 390.08 | 416.63 | 210.93 | Upgrade
|
| Net Income to Common | 405.45 | 499.22 | 477.69 | 390.08 | 416.63 | 210.93 | Upgrade
|
| Net Income Growth | -18.66% | 4.51% | 22.46% | -6.37% | 97.52% | 92.53% | Upgrade
|
| Shares Outstanding (Basic) | 82 | 82 | 80 | 80 | 80 | 80 | Upgrade
|
| Shares Outstanding (Diluted) | 82 | 82 | 80 | 80 | 80 | 80 | Upgrade
|
| Shares Change (YoY) | 0.40% | 2.44% | 0.24% | - | - | - | Upgrade
|
| EPS (Basic) | 4.94 | 6.08 | 5.96 | 4.88 | 5.21 | 2.64 | Upgrade
|
| EPS (Diluted) | 4.94 | 6.08 | 5.96 | 4.88 | 5.21 | 2.64 | Upgrade
|
| EPS Growth | -19.00% | 2.01% | 22.13% | -6.33% | 97.36% | 92.69% | Upgrade
|
| Free Cash Flow | - | 174.71 | 494.33 | 565.24 | 586.96 | 369.46 | Upgrade
|
| Free Cash Flow Per Share | - | 2.13 | 6.17 | 7.07 | 7.35 | 4.62 | Upgrade
|
| Dividend Per Share | 2.500 | 2.500 | 2.500 | 4.000 | - | 6.000 | Upgrade
|
| Dividend Growth | 66.67% | - | -37.50% | - | - | 300.00% | Upgrade
|
| Gross Margin | 59.97% | 59.61% | 58.83% | 58.16% | 54.55% | 55.71% | Upgrade
|
| Operating Margin | 12.62% | 15.80% | 17.58% | 16.46% | 17.92% | 15.43% | Upgrade
|
| Profit Margin | 9.06% | 12.26% | 11.94% | 10.80% | 12.35% | 8.69% | Upgrade
|
| Free Cash Flow Margin | - | 4.29% | 12.35% | 15.66% | 17.40% | 15.22% | Upgrade
|
| EBITDA | 692.12 | 770.94 | 831.82 | 715.61 | 724.06 | 491.33 | Upgrade
|
| EBITDA Margin | 15.46% | 18.94% | 20.79% | 19.82% | 21.46% | 20.24% | Upgrade
|
| D&A For EBITDA | 127.23 | 127.72 | 128.37 | 121.21 | 119.55 | 116.78 | Upgrade
|
| EBIT | 564.9 | 643.23 | 703.45 | 594.4 | 604.51 | 374.55 | Upgrade
|
| EBIT Margin | 12.62% | 15.80% | 17.58% | 16.46% | 17.92% | 15.43% | Upgrade
|
| Effective Tax Rate | 26.70% | 28.01% | 29.80% | 30.30% | 22.96% | 26.97% | Upgrade
|
| Revenue as Reported | 4,535 | 4,156 | 4,055 | 3,667 | 3,424 | 2,489 | Upgrade
|
| Advertising Expenses | - | 78.63 | 41.43 | 50.5 | 26 | 12.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.